Sarcoidosis MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sarcoidosis}} | {{Sarcoidosis}} | ||
{{CMG}} | {{CMG}} {{AE}}Roshan Dinparasti Saleh | ||
==Overview== | |||
Currently, cardiac MRI([[CMR]]) is the technique of choice in diagnosis of subclinical or clinical [[cardiac sarcoidosis]]. It is fast, accurate, and noninvasive. | |||
==MRI== | ==MRI== | ||
Currently, cardiac MRI and/or PET scanning is proposed to be most specific for diagnosis of cardiac sarcoidosis<ref>Hamzeh NY, Wamboldt FS, Weinberger HD: Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 2012, 141(1):154-162.</ref>. | |||
T1-weighted MR shows : | |||
* [[wall motion abnormalities]] | |||
* Hypertrophy due to infiltration | |||
* Wall thinning | |||
* [[Heart failure]] | |||
* [[Late gadolinium enhancement]] (delayed enhancement) evaluates scar/[[fibrosis]] and can differentiate chronic versus active disease. Some studies also suggest that monitoring [[gadolinium]] enhancement may be helpful in the assessment of response to treatment with [[steroids]]<ref>Abrishami B, O'Connel C, Sharma O: Cardiac sarcoidosis with presentation of large left atrial mass. Current opinion in pulmonary medicine 2004, 10(5):397-400.</ref><ref>Youssef G, Beanlands RS, Birnie DH, Nery PB: Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart (British Cardiac Society) 2011, 97(24):2078-2087.</ref><ref>Yeboah J, Lee C, Sharma OP: Cardiac sarcoidosis: a review 2011. Current opinion in pulmonary medicine 2011, 17(5):308-315.</ref>. | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 13:31, 6 May 2018
|
Sarcoidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sarcoidosis MRI On the Web |
|
American Roentgen Ray Society Images of Sarcoidosis MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roshan Dinparasti Saleh
Overview
Currently, cardiac MRI(CMR) is the technique of choice in diagnosis of subclinical or clinical cardiac sarcoidosis. It is fast, accurate, and noninvasive.
MRI
Currently, cardiac MRI and/or PET scanning is proposed to be most specific for diagnosis of cardiac sarcoidosis[1]. T1-weighted MR shows :
- wall motion abnormalities
- Hypertrophy due to infiltration
- Wall thinning
- Heart failure
- Late gadolinium enhancement (delayed enhancement) evaluates scar/fibrosis and can differentiate chronic versus active disease. Some studies also suggest that monitoring gadolinium enhancement may be helpful in the assessment of response to treatment with steroids[2][3][4].
References
- ↑ Hamzeh NY, Wamboldt FS, Weinberger HD: Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 2012, 141(1):154-162.
- ↑ Abrishami B, O'Connel C, Sharma O: Cardiac sarcoidosis with presentation of large left atrial mass. Current opinion in pulmonary medicine 2004, 10(5):397-400.
- ↑ Youssef G, Beanlands RS, Birnie DH, Nery PB: Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart (British Cardiac Society) 2011, 97(24):2078-2087.
- ↑ Yeboah J, Lee C, Sharma OP: Cardiac sarcoidosis: a review 2011. Current opinion in pulmonary medicine 2011, 17(5):308-315.